March 2020 Volume 16, Issue 3
Volume 16, Issue 3 | March 2020
March 2020
In this Issue
Feature
AACR 2020 Show Preview: Crafting better cancer care
The AACR Annual Meeting covers the best in cutting edge cancer research and careCancer therapies and insights up top
A roundup of recent research and development efforts in brain and lung cancersCommentary
Out of order: Developing solutions
As COVID-19 spreads, it can be a reminder that science and health research are community efforts, and to optimize our opportunities for success and serendipity, we must open that community as widely as we canMARKET INSIGHT: Key happenings in various markets and pipelines
A roundup of various insights from London-based data and analytics company GlobalData over the past couple months in multiple sectors of pharma, biotech and life sciencesResearch & Development
Take it from the top
Purdue University team creates tumor model of pancreatic cancer that elucidates disease progression from the beginningPotent pathogens
Researchers take aim at antibiotic-resistant bacteriaGetting the skinny on glutamate
A new sensor technique enables the measurement of glutamate usage by brain cells for the first timeOne swab, many results
Mawi DNA taps CosmosID to evaluate its iSwab-Microbiome sample collection offeringDiscovery
Deactivating liver fibrosis
UC San Diego researchers find transcription factors that can halt accumulation of liver scarring and encourage healingCell by cell
Researchers release a single-cell atlas examining changes in gene expression in Alzheimer’s disease beyond neuronsAI and antibodies align
Three-year collaboration capitalizes on AI to develop therapeutic monoclonal antibodiesAiding drug discovery
Almirall and Iktos announce a research collaboration for new drug designSeeking candidates for Takeda
Integrated drug discovery collaboration will focus on Takeda’s four core therapeutic areasClinical Trials
Fighting back against FOP
Regeneron reports encouraging garetosmab Phase 2 results in patients with ultra-rare bone diseaseNew possibilities in women’s health
SCYNEXIS studies a new candidate in the fight against yeast infectionPeanut problem
Company tests peanut allergy therapy for childrenA good start for fosciclopirox
CicloMed shares Phase 1 results of its lead candidate in bladder cancerFighting COVID-19 effectively
Worldwide research and collaboration needed to combat the coronavirus, says GlobalDataEditor's Focus
Editor’s Focus: Let’s talk about the C-word, shall we?
Cancer news and events are the name of the game in much of the March issue of DDNewsSpecial Reports
Special Report on Proteomics: Profiles in prognostication
Protein biomarkers go in search of clinical validityContract Services
Partners wanted for base editing platform
Horizon wants to assess state of the technology and guide its future shapeAn IP partnership
Arctoris partners with Molecule to tackle the innovation crisis in drug discovery and developmentMonoclonal movements
GHO Capital invests in FairJourney, provider of monoclonal antibody discovery servicesDiagnostics
A ‘liquid’ asset
Liquid biopsy aims to accelerate biomarker-driven precision cancer therapiesZeroing in on prostate cancer
Validation study recently completed on miR Scientific’s Sentinel testsEyes are windows to the...brain?
C. Light Technologies uses retinal tracking and AI as a new tactic for neurological diagnosisPreclinical
All that glitters
Clene Nanomedicine’s CNM-Au8 gold nanocrystals effectively induce remyelination in preclinical modelsCue up a potential answer to fighting tumors
Cue Biopharma’s preclinical and translational data support potential of CUE-101 in HPV16-related malignanciesSaving the brain
Study shows more effective, safer way to develop stem cells for treating brain damageINDY inhibition attenuates diet-induced NASH
Eternygen presents data positioning mINDY inhibitors as novel therapeutic option in NASHBusiness & Government Policy
Diabetes deterrent
Gene therapy approach reprograms beta cells in the pancreasOn the cutting edge
A roundup of instrumentation, software and other tools and technology newsPromoting more cancer R&D
Start Codon joins Cancer Research UK’s Entrepreneurial Programmes InitiativeTurning bad fat into good fat
Purdue alumnus makes an investment that could help curb obesity and diabetes
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Reliable fluid biomarkers strategies for clinical neuroscience research
Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Understanding drug impurities: types, sources, and analytical strategies
Unseen and often unexpected, drug impurities can slip in at every drug development stage, making their detection and control essential.
Discovering cutting-edge nitrosamine analysis in pharmaceuticals
New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
